Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

NCPA Annual Meeting RECAP Show | Part One Nov 10, 2025

Show notes

Welcome to the Pharmacy Podcast Network's coverage of the NCPA 2025 Post Show! The NCPA annual conference is the trailblazer for community pharmacy, bringing together the pharmacy community. Our host Todd Eury, founder and CEO of the Pharmacy Podcast Network, took the microphone to the action right on the show floor capturing exclusive conversations with attendees, pharmacy students, keynote speakers, vendors, and more!

Thank you RealValueRx for sponsoring this episode!

realvaluerx.com

In this episode:

JD Collier - RealValueRx

Rachel Matz - DocStation

Johny Kello - MatchRx

John DeJames

Stephanie Zimmerman - Real Value Rx; Jay Phipps

Brad Gallagher - Barclay Damon LLP

Scotty Sikes - Sikes and Co

David Kirkus - PrimeRx

Evan Walker - P3 Pharmacy Student

The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx Nov 07, 2025

Show notes

This Week in Pharmacy - November 7, 2025

TWIRx News: First up, Binghamton University School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, and Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans.

Our special guest line up on TWIRx:

Amantha Bagdon - CEO of RxPost
PGX Pharmacist's Protection of Patients with Dr. Melissa Smith PharmD
Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI
4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD

Thank you toour sponsors:

Independent Pharmacy Cooperative (IPC)
Yaral Pharma
SureCost

The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx

OvaryIt: Breaking Barriers to Birth Control with Pharmacists at the Center | MaternalRx Nov 06, 2025

Show notes

On this episode of MaternalRx on the Pharmacy Podcast Network, host Dr. Danielle Raiman Plummer, PharmD, consulting pharmacist, sits down with Mary Kucek, PMP, and Dr. Devin Bustin, MD, co-founders of OvaryIt, creators of the PRISM EHR platform and the OvaryIt Foundation for survivors of domestic abuse and human trafficking.
Mary shares her powerful and life-threatening experience with a telemedicine platform that failed to follow contraceptive safety guidelines, an event that changed the course of her career and mission. Together, Mary and Dr. Bustin explain how their NIH-funded research led to the creation of OvaryIt and PRISM: an innovative, pharmacist-centered platform that bridges the safety of in-person care with the accessibility of telehealth.
Tune in to hear how retail pharmacists can now lead the next evolution in family planning access, overcoming the barriers to scaling these services, and how technology and policy can empower safer, more equitable reproductive care for all.
“Prism will help retail pharmacies become public health access points for central health services.”
💡 Stay Connected & Take Action!
- Follow OvaryIt on all social platforms to stay updated on their mission to expand safe, pharmacist-led access to reproductive care.
- For Patients: Learn more or find care at MyPrismHealth.com.
- For Pharmacists, Pharmacy Owners, and Staff: Discover how to bring contraceptive care to your community with GetPrismRx.com.
- Explore Free Education & Advocacy: Visit OvaryFund.org — the OvaryIt Foundation supporting survivors of domestic abuse and human trafficking through education and access.
- Advocate for Change: Contact your local representatives to support the ECAPS Act, which recognizes pharmacists as healthcare providers under Medicare Part B and helps expand access to essential reproductive health services.
Disclaimer: This podcast is for educational purposes only and should not replace medical advice.
🎧 Listen now to MaternalRx, redefining maternal health, from preconception through postpartum.

Preventable Toxicity: The Pharmacogenomics Case for DPYD Testing in Oncology | Precision Medicine Pharmacist Podcast Nov 05, 2025

Show notes

Fluoropyrimidines such as 5-fluorouracil (5-FU) and capecitabine remain cornerstone chemotherapies in oncology. However, for patients with certain DPYD gene variants, these commonly used drugs can cause life-threatening toxicities due to impaired metabolism of the active compounds.
In this episode of the Precision Medicine Pharmacist Podcast, host Melissa Smith, PharmD, explores how DPYD genotyping is transforming oncology care by helping clinicians identify patients at risk before toxicity occurs. Joined by Karen Merritt, an advocate for universal DPD testing and leader with the Test4DPD initiative, the discussion sheds light on how pharmacogenomics is shaping safer, more personalized cancer treatment.
Together, they explore current evidence, new FDA updates, and implementation frameworks that empower pharmacists and oncology teams to prevent preventable harm through precision medicine.
🧠 Key Discussion Topics

The science behind DPYD gene variants and their clinical implications
How undiagnosed DPD deficiency contributes to preventable toxicity
New recommendations from the CPIC® Guideline for Fluoropyrimidines and DPYD
Insights from the Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines
Advocacy for universal DPYD testing across oncology centers
How pharmacists can champion pharmacogenomic testing integration in oncology workflows
Updates from the FDA-approved labeling for Xeloda (capecitabine)

🎧 Featured Guest Karen Merritt
LinkedIn Profile
Karen Merritt is a passionate advocate for pharmacogenomic testing and patient safety in oncology care. Through her leadership in the Test4DPD movement, she works to expand awareness and adoption of DPYD testing worldwide, ensuring patients are protected from severe chemotherapy-related toxicities.
📚 Resources & References

💊 About the Show
The Precision Medicine Pharmacist Podcast explores the evolving role of pharmacists in precision health, pharmacogenomics, and individualized patient care. Each episode highlights clinical insights, implementation strategies, and inspiring stories from professionals leading the way in personalized medicine.

Inside M3P: What Medicare Providers and Patients Need to Know | NASP Specialty Pharmacy Podcast Nov 04, 2025

Show notes

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Sheri Wallace, Account Representative at AcariaHealth Specialty Pharmacy, and Diane Omdahl, RN, MS, founder of 65 Incorporated, published author and consultant on Medicare, to unpack the complexities of the Medicare Prescription Payment Plan (MPPP). Drawing on decades of patient access experience and the finer points of Medicare, they share insights on how these changes impact patients, providers, and pharmacies alike. Learn the importance of education, transparency, and advocacy in ensuring patients don’t fall through the cracks during these changes. Whether you're a provider, pharma partner, or patient advocate, this episode offers practical guidance and expert perspectives to help you navigate the evolving Medicare landscape.

Xplore: Growth, Technology, Connections, and Solutions | PrimeRx User Conference Part One Nov 03, 2025

Show notes

The Pharmacy Podcast Network attended Xplore 2025, PrimeRx's Inaugural User Conference, capturing the voices of independent pharmacy owners, students, and industry leaders. In this episode, Todd Eury talks with:

Ashton Maaraba with IPC iCare+

Leo Gjoni with DrugLift

Ayah Elzibak, Pharmacy Student

Will Tuft with RxSafe Eyecon

Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx Oct 31, 2025

Show notes

TWIRx in the WORKS!!! Welcome back to This Week in Pharmacy (TWIRx) — your weekly deep dive into the most important pharmacy news, innovations, and conversations shaping healthcare.
In this episode, host Todd Eury brings you stories that move from data to impact, exploring how pharmacists are driving change through knowledge, leadership, and advocacy.
🗞️ TWIRx News Roundup
Wrapping up IDWeek 2025 with the latest insights from Pharmacy Practice News and more breaking updates across the profession:

💊 How Well Are You Using Fetroja?
Understanding appropriate use of cefiderocol and antibiotic resistance challenges.
🔗 Read at Pharmacy Practice News

⚕️ AFPs Affect Access to Specialty Medications
Learn how alternative funding programs are impacting patient access and specialty care.
🔗 Read at Specialty Pharmacy Continuum

🚨 FDA Recall Alert
Drug makers recall a blood pressure medicine tainted with a cancer-causing chemical.
🔗 Read the full story via AP News

🧠 Meeting Patients Where They Are
How pharmacists are supporting patients managing schizophrenia treatment adherence.
🔗 Read at Pharmacy Times

🎤 Featured Guest: Keith Kallmes
President, Nested Knowledge
A deep conversation on how Nested Knowledge is transforming the way clinical data becomes actionable insights for healthcare decision-makers.
Connect with Keith on LinkedIn

🧬 Today’s TWIRx is sponsored by Nested Knowledge — advancing research automation and evidence synthesis to accelerate medical innovation.
💪 31-Day Pharmacist Challenge
A huge thank you to Dr. Jesse McCullough, PharmD — Founder of Keystone Pharmacy Insights — for inspiring the pharmacy community through the 31-Day Pharmacist Challenge during Pharmacist Month!
Connect with Jesse on LinkedIn
Join his Leadership Community for Pharmacists on SKOOL

🔥 Bonus Guest: Matthew Zachary
Principal, Matthew Zachary Worldwide
The outspoken healthcare advocate returns to rage against the PBM Mafia, shining a light on the broken business models of the “Big 3” PBMs.
Shout-out to Mark Cuban Cost Plus Drugs for disrupting the system and fighting for transparency and affordability for patients everywhere.
📢 Subscribe & Connect
Stay tuned to This Week in Pharmacy (TWIRx) for the most relevant stories, data insights, and voices advancing the future of pharmacy care.
Follow the Pharmacy Podcast Network on:
🌐 PharmacyPodcast.com
🔗 LinkedIn | X | YouTube | Spotify | Apple Podcasts Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx

Lies and Lawsuits | Essential: Pharmacy Compounding Podcast APC Oct 30, 2025

Show notes

In this edition of Essential, we look at how we’re pushing back against the FDA’s upcoming ban on desiccated thyroid extract, why drugmakers’ latest tactics against compounding pharmacies are backfiring, and we give you a great way to make sure your practice is performing at its best.
Then we take a deep dive with attorney and pharmacist Mark Boesen into the lawsuits being filed against compounding pharmacies, what the results have been, and how they might affect more than just pharmacy in the future.
Boesen & Snow Law: https://www.boesensnowlaw.com/
DTE story (https://a4pc.org/news/ask-your-patients-help-us-protect-dte-access)
“FDA’s confusing warning letters” (https://a4pc.org/news/fdas-confusing-warning-letters)
“FDA’s green list: Not our problem?” (https://a4pc.org/news/fdas-green-list-not-our-problem)
Compounding.com/thyroid
Best practices documents (a4pc.org/bestpractices)
National Review article on FDA crackdown (https://archive.ph/LYy7t)

NSAIDs: Everything and Then Some | Pain Pod Oct 29, 2025

Show notes

NSAIDs are everywhere, prescription, OTC, topical, oral, injectable, you name it!
In an era of Opioidphobia, are they really a panacea? Heck no, all medications come with baggage.
We could spend hours talking about NSAIDs, and not even get to the elephant in the room: Which NSAID for Which Patient? So we’ll go there in this succinct, yet comprehensive rapid review of all things NSAIDs on the Pain Pod!
Come one, come all, to the Pain Pod!!!
Pain Guy
• www.painguy.us

KIDs List Lowdown | Pediatric Pharmacist Review Oct 28, 2025

Show notes

In this episode of The Pediatric Pharmacist Review, we delve into the 2025 KIDs List—the Pediatric Pharmacy Association's updated guide highlighting key potentially inappropriate medications in pediatric care. This comprehensive list serves as a critical resource for clinicians aiming to enhance medication safety and optimize pharmacotherapy in pediatric populations.
Meet the Experts:
Dr. Rachel S. Meyers brings a wealth of experience as a Clinical Professor at Rutgers University and a Pediatric Clinical Pharmacist at Cooperman Barnabas Medical Center. Her clinical insights and academic contributions have significantly influenced pediatric pharmacy practice.
Dr. David Hoff serves as the Pharmacy Director for Acute Care at Children’s Minnesota and holds the position of Section Editor at JPPT. With over 30 years of experience, he has been instrumental in developing and updating the KIDs List, ensuring it reflects the latest evidence and best practices.
Key Discussion Points:
The evolution and significance of the KIDs List in pediatric pharmacotherapy
Strategies for integrating the KIDs List into clinical practice
The impact of inappropriate medications on pediatric patient outcomes
Collaborative efforts in pediatric medication safety
Further Reading:
For a comprehensive understanding, access the full 2025 KIDs List here: 2025 KIDs List PDF

Related Podcasts